GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Cyclically Adjusted PS Ratio

HLB Panagene Co (XKRX:046210) Cyclically Adjusted PS Ratio : (As of Sep. 27, 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


HLB Panagene Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for HLB Panagene Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Panagene Co Cyclically Adjusted PS Ratio Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.05 9.37 11.40 13.00 11.82

HLB Panagene Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.84 10.90 11.82 14.24 -

Competitive Comparison of HLB Panagene Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, HLB Panagene Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Panagene Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Panagene Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HLB Panagene Co's Cyclically Adjusted PS Ratio falls into.



HLB Panagene Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

HLB Panagene Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, HLB Panagene Co's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=59.976/*
=

Current CPI (Jun. 2024) = .

HLB Panagene Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 37.747 99.608 0.000
201412 46.032 99.098 0.000
201503 45.397 99.720 0.000
201506 53.589 100.050 0.000
201509 52.231 100.110 0.000
201512 64.562 100.220 0.000
201603 54.777 100.560 0.000
201606 60.557 100.790 0.000
201609 59.296 101.460 0.000
201612 68.926 101.560 0.000
201703 53.922 102.850 0.000
201706 66.169 102.610 0.000
201709 51.604 103.490 0.000
201712 65.021 102.990 0.000
201803 70.227 104.100 0.000
201806 65.520 104.130 0.000
201809 50.643 105.650 0.000
201812 56.717 104.350 0.000
201903 68.604 104.490 0.000
201906 58.063 104.880 0.000
201909 64.416 105.200 0.000
201912 53.388 105.120 0.000
202003 81.672 105.540 0.000
202006 147.520 104.870 0.000
202009 126.696 106.200 0.000
202012 154.511 105.765 0.000
202103 108.051 107.357 0.000
202106 135.605 107.579 0.000
202109 136.232 108.759 0.000
202112 104.309 109.676 0.000
202203 146.078 111.806 0.000
202206 90.649 114.083 0.000
202209 105.471 114.831 0.000
202212 101.852 115.200 0.000
202303 97.628 116.550 0.000
202306 85.974 117.140 0.000
202309 75.245 119.111 0.000
202312 64.776 118.848 0.000
202403 83.505 118.848 0.000
202406 59.976 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


HLB Panagene Co  (XKRX:046210) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


HLB Panagene Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co Business Description

Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co Headlines

No Headlines